Cogent Biosciences (COGT) Enterprise Value (2017 - 2021)
Historic Enterprise Value for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to -$202.9 million.
- Cogent Biosciences' Enterprise Value fell 5676.71% to -$202.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$202.9 million, marking a year-over-year decrease of 5676.71%. This contributed to the annual value of -$242.2 million for FY2020, which is 54715.16% down from last year.
- According to the latest figures from Q3 2021, Cogent Biosciences' Enterprise Value is -$202.9 million, which was down 5676.71% from -$218.1 million recorded in Q2 2021.
- Over the past 5 years, Cogent Biosciences' Enterprise Value peaked at -$21.3 million during Q2 2020, and registered a low of -$242.2 million during Q4 2020.
- Its 5-year average for Enterprise Value is -$107.1 million, with a median of -$82.5 million in 2018.
- In the last 5 years, Cogent Biosciences' Enterprise Value soared by 6187.75% in 2019 and then crashed by 92195.2% in 2021.
- Over the past 5 years, Cogent Biosciences' Enterprise Value (Quarter) stood at -$49.6 million in 2017, then tumbled by 97.56% to -$97.9 million in 2018, then soared by 61.79% to -$37.4 million in 2019, then plummeted by 547.15% to -$242.2 million in 2020, then increased by 16.23% to -$202.9 million in 2021.
- Its Enterprise Value stands at -$202.9 million for Q3 2021, versus -$218.1 million for Q2 2021 and -$230.7 million for Q1 2021.